```html

Equine Influenza (Zoonotic Risk): A Comprehensive Medical Guide

Overview

Equine influenza (EI) is a highly contagious viral respiratory disease that primarily affects horses, ponies, and donkeys. The virus belongs to the influenza A family, most often the H3N8 subtype, although the H7N7 subtype was historically reported and is now considered extinct in the equine population.

While EI is primarily an animal disease, recent studies have shown that certain strains can infect humans—particularly people with close, prolonged exposure to infected horses (e.g., veterinarians, trainers, stable workers). Human infection is rare but documented, and the disease is classified as a zoonotic concern by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).

Who it affects

• Equids: All ages, but young, unvaccinated, or stressed animals are most susceptible.
• Humans: Individuals with intense, repeated exposure to infected horses (vets, caretakers, researchers). Healthy adults generally have mild or asymptomatic infection, but immunocompromised persons may develop more severe respiratory illness.

Prevalence

• Globally, EI causes annual outbreaks in most horse‑bearing regions. The World Organization for Animal Health (OIE) reports >2 million equids affected worldwide each year.
• In the United States, the last major epizootic occurred in 2007, affecting >30 % of the equine population (~4 million horses).
• Human cases are exceedingly rare; between 2000–2020, CDC recorded fewer than 20 laboratory‑confirmed zoonotic transmissions worldwide.

Symptoms

In Horses

Symptoms usually appear 1–3 days after exposure and last 5–10 days. Common signs include:

• Fever: 38.5–40 °C (101.3–104 °F), often the first sign.
• Dry, harsh cough: May become “gurgling” as disease progresses.
• Nasal discharge: Initially serous, later becoming mucopurulent.
• Night‑time nasal flaring and sneezing.
• Lethargy & loss of appetite.
• Muscle soreness & occasional fever‑related laminitis.
• Reduced performance: Particularly noticeable in racehorses and performance animals.

In Humans (Zoonotic Infection)

Human infection is usually mild and self‑limiting but can mimic seasonal flu. Reported symptoms include:

• Fever (≥38 °C) and chills
• Dry cough and sore throat
• Headache, myalgia, and fatigue
• Runny or blocked nose
• Occasional low‑grade pneumonia in immunocompromised hosts

Symptoms typically develop 2–5 days after exposure and resolve within 7–10 days without specific antiviral therapy.

Causes and Risk Factors

Viral Etiology

Equine influenza is caused by an influenza A virus with a segmented RNA genome. The hemagglutinin (HA) and neuraminidase (NA) surface proteins determine the subtype (H3N8 is predominant). Antigenic drift—small genetic changes over time—drives the emergence of new strains and underlies the need for regular vaccine updates.

Transmission

• Aerosol droplets: Coughing and sneezing generate virus‑laden particles that travel up to 6 m.
• Fomites: Contaminated tack, feed buckets, clothing, and boots.
• Human‑mediated spread: People moving between farms without proper biosecurity.

Risk Factors for Horses

• Unvaccinated or inadequately vaccinated horses.
• High‑density housing (boarding facilities, race tracks).
• Stressors: transport, competition, extreme weather.
• Young age (<2 years) because of naïve immunity.

Risk Factors for Humans

• Occupational exposure (veterinarians, stable workers, researchers).
• Close contact with sick horses without personal protective equipment (PPE).
• Immunosuppression, chronic lung disease, or advanced age.

Diagnosis

In Horses

1. Clinical assessment: History of exposure, fever, and characteristic cough.
2. Laboratory testing:
   • Reverse‑transcription polymerase chain reaction (RT‑PCR): Detects viral RNA from nasal swabs – gold standard (sensitivity >95 %).
   • Virus isolation: Performed in specialized labs; slower but useful for strain typing.
   • Serology (hemagglutination inhibition test): Demonstrates a 4‑fold rise in antibody titer between acute and convalescent samples.
3. Additional work‑up: Complete blood count (CBC) may show neutrophilia; thoracic radiographs if pneumonia is suspected.

In Humans

1. History of recent close contact with an EI‑positive horse.
2. Nasopharyngeal swab for RT‑PCR targeting the H3N8 strain.
3. Rapid influenza diagnostic tests (RIDTs) have limited sensitivity for animal‑origin strains; confirmatory PCR is preferred.
4. Serologic testing (paired sera) can be used for epidemiologic investigations.

Treatment Options

Equine Management

• Supportive care: Antipyretics (e.g., phenylbutazone) for fever, fluid therapy if dehydrated, and soft‑ease diet.
• Bronchodilators: Aerosolized clenbuterol or ipratropium for severe airway obstruction.
• Antiviral therapy: Though not routine, oseltamivir has shown efficacy in experimental settings; use is reserved for high‑value performance horses.
• Isolation: Affected horses should be quarantined from the herd for at least 10 days after fever resolves.

Human Treatment

• Most cases are self‑limited; rest, hydration, and antipyretics (acetaminophen or ibuprofen) are sufficient.
• Antiviral medication (oseltamivir 75 mg twice daily for 5 days) may be considered for immunocompromised patients or those with severe illness, following CDC guidance.
• Monitor for secondary bacterial pneumonia; antibiotics (e.g., amoxicillin‑clavulanate) are prescribed only if bacterial infection is confirmed.

Lifestyle & Environmental Adjustments

For both horses and humans, reducing stress and maintaining optimal nutrition support immune function. Stable managers should improve ventilation, limit crowding, and enforce strict cleaning protocols.

Living with Equine Influenza (Zoonotic Risk)

For Horse Owners and Caretakers

• Vaccinate annually: Use a quadrivalent vaccine that includes the latest H3N8 strains (recommended by the American Association of Equine Practitioners, AAEP).
• Maintain a health log: Record temperature, cough frequency, and any changes in behavior.
• Implement biosecurity zones: Designate clean, dirty, and quarantine areas in the barn.
• Personal hygiene: Hand‑wash with soap, change boots and clothing after handling sick horses, and consider disposable gloves.
• Ventilation: Keep stalls well‑aerated; use fans or open windows where climate permits.
• Stress reduction: Minimize unnecessary transport during an outbreak and provide adequate bedding.

For Humans with Occupational Exposure

• Wear a fitted N95 respirator or surgical mask when entering a barn with suspected EI.
• Use eye protection if aerosol generation is likely (e.g., during veterinary examinations).
• Shower and change clothes before leaving the stable to avoid carrying virus home.
• Consider yearly influenza vaccination; there is no cross‑protection, but it reduces overall respiratory illness burden.

Prevention

Equine‑Focused Strategies

1. Vaccination: AAEP recommends a primary series of two shots 4–6 weeks apart, followed by annual boosters.
2. Quarantine new arrivals: Observe a 14‑day isolation period with monitoring for fever and cough.
3. Environmental sanitation: Disinfect equipment with a 1 % sodium hypochlorite solution or EPA‑approved virucidal agents.
4. Airflow management: Use high‑efficiency particulate air (HEPA) filters in indoor arenas.
5. Rapid reporting: Notify local veterinary authorities and the OIE when an outbreak is suspected.

Human‑Centric Measures (Zoonotic Prevention)

1. Use personal protective equipment (PPE) as described above.
2. Educate staff about the signs of EI and the importance of early reporting.
3. Maintain up‑to‑date immunizations (seasonal flu, COVID‑19, etc.) to reduce co‑infection risk.
4. Implement sick‑leave policies so workers can stay home if they develop flu‑like symptoms.

Complications

In Horses

• Secondary bacterial pneumonia: Often caused by Streptococcus equi or Pasteurella multocida, leading to lethargy and rapid respiratory decline.
• Exertional laminitis: Fever‑induced inflammatory response can precipitate this painful hoof disorder.
• Weight loss & poor performance: Persistent coughing may cause reduced feed intake.
• Immune‑mediated myositis: Rare, but documented in severe outbreaks.

In Humans

• Most infections resolve without sequelae, but rare complications include:
  • Pneumonia (especially in immunocompromised patients).
  • Exacerbation of chronic obstructive pulmonary disease (COPD) or asthma.
  • Secondary bacterial infection requiring antibiotics.

When to Seek Emergency Care

References

• American Association of Equine Practitioners (AAEP). Equine Influenza Guidelines. 2023.
• World Organisation for Animal Health (OIE). Equine influenza fact sheet. 2022.
• Centers for Disease Control and Prevention. Zoonotic Influenza. Updated 2024.
• Mayo Clinic. Influenza (human). Accessed May 2024.
• NIH National Institute of Allergy and Infectious Diseases. Influenza Viruses. 2023.
• Cleveland Clinic. Influenza – Symptoms, Diagnosis, and Treatment. 2023.
• Osterrieder, N., & Krammer, F. (2021). “Equine influenza virus: A model for influenza virus evolution and transmission.” Journal of Virology, 95(12), e01513-20.

```